Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Mol Neurobiol ; 23(3): 379-400, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12825834

ABSTRACT

1. The effect of adenosine analogues and of nucleotides, alone or in combination, on intracellular calcium, accumulation of inositol (1,4,5) trisphosphate (InsP3), and on activation of protein kinase C (PKC) was studied in DDT1 MF2 cells derived from a Syrian hamster myosarcoma. These cells were found to express mRNA for A1 and some as yet unidentified P2Y receptor(s). 2. Activation of either receptor type stimulated the production of InsP3 and raised intracellular calcium in DDT1 MF2 cells. Similarly, the A1 selective agonist N6-cyclopentyladenosine (CPA) increased PKC-dependent phosphorylation of the substrate MBP(4-14) and induced a PKC translocation to the plasma membrane as determined using [3H]-phorbol dibutyrate (PDBu) binding in DDT1 MF-2 cells. However, neither adenosine nor CPA induced a significant translocation of transiently transfected gamma-PKC-GFP from the cytosol to the cell membrane. In contrast to adenosine analogues, ATP and UTP also caused a rapid but transient translocation of gamma-PKC-GFP and activation of PKC. 3. Doses of the A1 agonist CPA and of ATP or UTP per se caused barely detectable increases in intracellular Ca2+ but when combined, they caused an almost maximal stimulation. Similarly, adenosine (0.6 microM) and UTP (or ATP, 2.5 microM), which per se caused no detectable translocation of either gamma- or epsilon-PKC-GFP, caused when combined a very clear-cut translocation of both PKC subforms, albeit with different time courses. These results show that simultaneous activation of P2Y and adenosine A1 receptors synergistically increases Ca2+ transients and translocation of PKC in DDT1 MF-2 cells. Since adenosine is rapidly formed by breakdown of extracellular ATP, such interactions may be biologically important.


Subject(s)
Calcium Signaling/drug effects , Cell Membrane/drug effects , Myocytes, Smooth Muscle/drug effects , Protein Kinase C/drug effects , Purinergic P1 Receptor Agonists , Receptors, Purinergic P2/drug effects , Adenosine/analogs & derivatives , Adenosine/pharmacology , Adenosine Triphosphate/metabolism , Adenosine Triphosphate/pharmacology , Animals , Calcium Signaling/physiology , Cell Membrane/enzymology , Cricetinae , Drug Synergism , Green Fluorescent Proteins , Inositol 1,4,5-Trisphosphate/metabolism , Intracellular Fluid/drug effects , Intracellular Fluid/metabolism , Luminescent Proteins , Myocytes, Smooth Muscle/cytology , Myocytes, Smooth Muscle/enzymology , Protein Isoforms/drug effects , Protein Isoforms/metabolism , Protein Kinase C/metabolism , Protein Transport/drug effects , Protein Transport/physiology , Receptors, Purinergic P1/metabolism , Receptors, Purinergic P2/metabolism , Receptors, Purinergic P2Y1 , Recombinant Fusion Proteins/pharmacology , Tumor Cells, Cultured , Uridine Triphosphate/metabolism , Uridine Triphosphate/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...